Utility of IL-6 in the Diagnosis, Treatment and Prognosis of COVID-19 Patients: A Longitudinal Study
COVID-19 has caused devastating effects worldwide ever since its origin in December 2019. IL-6 is one of the chief markers used in the management of COVID-19. We conducted a longitudinal study to investigate the role of IL-6 in diagnosis, treatment, and prognosis of COVID-19-related cytokine storm....
Main Authors: | Vikram Jain, Pratap Kumar, Prasan Kumar Panda, Mohan Suresh, Karanvir Kaushal, Anissa A. Mirza, Rohit Raina, Sarama Saha, Balram J. Omar, Vivekanandhan Subbiah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/11/1786 |
Similar Items
-
Clinical and Laboratory Features of COVID-19 in Ulin Referral Hospital of South Kalimantan: Predictors of Clinical Outcome
by: Haryati, et al.
Published: (2021-09-01) -
Selected Predictors of COVID-19 Mortality in the Hospitalised Patient Population in a Single-Centre Study in Poland
by: Joanna Jaskolowska, et al.
Published: (2023-03-01) -
Association of interleukin-6, ferritin, and lactate dehydrogenase with venous thromboembolism in COVID-19: a systematic review and meta-analysis
by: Haiyu Liu, et al.
Published: (2024-03-01) -
D-dimer and ferritin levels in prediction of COVID-19 severity
by: Hujaz Ismail Abdulrazzaq Alqirbi, et al.
Published: (2023-01-01) -
Prognostic Values of Serum Ferritin and D-Dimer Trajectory in Patients with COVID-19
by: Fares Qeadan, et al.
Published: (2021-03-01)